Andrew Hamer

Chief Tech/Sci/R&D Officer at CARDIOL THERAPEUTICS INC.

Net worth: 710 144 $ as of 2026-06-29

64 year

Health Technology

Consumer Services

Profile

Andrew Hamer is Chief Medical Officer, Head-Research & Development at Cardiol Therapeutics, Inc. since 2021.
Formerly, Dr. Hamer was Executive Director-Global Development at Amgen, Inc. from 2018 to 2021.
Dr. Hamer was Vice President-Medical Affairs at Capricor Therapeutics, Inc. from 2013 to 2015 and also held the position of Vice President-Medical Affairs at Capricor, Inc. Dr. Hamer completed undergraduate education at the University of Otago.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CARDIOL THERAPEUTICS INC. CLASS A 0.58%	2025-12-02	669,947 ( 0.58% )	710 144 $	2026-06-29

Andrew Hamer active positions

Companies	Position	Start
CARDIOL THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	2021-03-28

All active positions of Andrew Hamer

Former positions of Andrew Hamer

Companies	Position	End
AMGEN INC.	Corporate Officer/Principal	2021-02-28
CAPRICOR THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2015-07-29
Capricor, Inc. Capricor, Inc. BiotechnologyHealth Technology Provides cardiac stem cell therapeutics biotechnology services	Chief Tech/Sci/R&D Officer	-

See the detail of Andrew Hamer's experience

Training of Andrew Hamer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Hamer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Capricor, Inc. Capricor, Inc. BiotechnologyHealth Technology Provides cardiac stem cell therapeutics biotechnology services	Health Technology
University of Otago University of Otago Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Capricor Therapeutics, Inc. Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases	Health Technology
Cardiol Therapeutics, Inc. Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease	Health Technology